Goldman Sachs
PHGE icon

Goldman Sachs’s BiomX PHGE Stock Holding History

Goldman Sachs’s Portfolio PHGE Stock Details PHGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-80
Closed -$106K – 5415
2020
Q1 		$106K Buy
+80
New +$140K ﹤0.01% 4930

Other funds holding PHGE

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TWMP
Taylor Wealth Management Partners Boston, Massachusetts $176M AUM 14.65% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs's PHGE Position: Q2 2020 in Review

Goldman Sachs sold out of BiomX (PHGE) in Q2 2020, closing a stake of 80 shares — an estimated $106K sold.

Goldman Sachs first reported a position in PHGE in Q1 2020 and held it in 1 quarter. The position peaked at $106K in Q1 2020. 12 funds tracked by Wall St. Rank hold PHGE as of Q2 2020.

  • Goldman Sachs reported no remaining BiomX position as of Q2 2020 after selling out during the quarter.
  • Goldman Sachs sold 80 BiomX shares in Q2 2020, an estimated $106K.
  • Goldman Sachs first reported a position in BiomX in Q1 2020 and held it in 1 quarter.
  • Goldman Sachs's BiomX position peaked at $106K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held BiomX as of Q2 2020.

Based on Goldman Sachs's 13F filing for Q2 2020, filed 12 Aug 2020.